Skip to content
zarza zarza
Advertisement

ASCO '19

06/06/2019 18 min
ASCO '19

Episode Synopsis

Concise reviews of 6 studies from ASCO '19. #Oncopharm agents discussed include olaparib, ribociclib, pembrolizumab, dabrafenib/trametinib, and *losartan.

*caveats apply

ZARZA Studio — Your station on air today: library, music clock, schedule, studio and reports, from the browser.

Meet ZARZA Studio
on air now stations in the catalogue 1,829,025 podcasts countries